Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni G Camici

Showing results (131-140 of 179) with videos related to

Pageof 18
Sort By:
Cardiovascular Research|August 22, 2022
SGLT-2 inhibition by empagliflozin has no effect on experimental arterial thrombosis in a murine model of low-grade inflammationLuca Liberale, Simon Kraler, Yustina M Puspitasari, et al.
Vascular Pharmacology|July 19, 2024
Antithrombotic properties of Tafamidis: An additional protective effect for transthyretin amyloid cardiomyopathy patientsStefano Ministrini, Rebecca Niederberger, Alexander Akhmedov, et al.
European Heart Journal|January 10, 2017
Ticagrelor, but not clopidogrel active metabolite, displays antithrombotic properties in the left atrial endocardiumMartin F Reiner, Alexander Breitenstein, Erik W Holy, et al.
Kidney International|May 9, 2018
The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease riskEva-Maria Pastor-Arroyo, Nicole Gehring, Christiane Krudewig, et al.
International Journal of Cardiology|July 16, 2018
Corrigendum to 'Sirtuin 5 as a novel target to blunt blood-brain barrier damage induced by cerebral ischemia/reperfusion injury' [Int. J. Cardiol. 260 (2018) 148-155]Candela Diaz-Cañestro, Mario Merlini, Nicole R Bonetti, et al.
Thrombosis Research|December 16, 2018
Gut microbiota-dependent trimethylamine-N-oxide (TMAO) shows a U-shaped association with mortality but not with recurrent venous thromboembolismMartin F Reiner, Daniel Müller, Sara Gobbato, et al.
Cardiovascular Research|February 16, 2017
Endothelial LOX-1 activation differentially regulates arterial thrombus formation depending on oxLDL levels: role of the Oct-1/SIRT1 and ERK1/2 pathwaysAlexander Akhmedov, Giovanni G Camici, Martin F Reiner, et al.
European Heart Journal|May 14, 2022
Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts premature death in acute coronary syndromesSimon Kraler, Florian A Wenzl, Georgios Georgiopoulos, et al.
Cardiovascular Research|November 11, 2024
miR-24-3p secreted as extracellular vesicle cargo by cardiomyocytes inhibits fibrosis in human cardiac microtissuesGiorgia Senesi, Alessandra M Lodrini, Shafeeq Mohammed, et al.
Journal of the American Heart Association|June 1, 2023
Omega-3 Fatty Acids and Heart Rhythm, Rate, and Variability in Atrial FibrillationPhilipp Baumgartner, Martin F Reiner, Andrea Wiencierz, et al.
Pageof 18

Showing results (131-140 of 179) with videos related to

Sort By:
Pageof 18
Cardiovascular Research|August 22, 2022
SGLT-2 inhibition by empagliflozin has no effect on experimental arterial thrombosis in a murine model of low-grade inflammationLuca Liberale, Simon Kraler, Yustina M Puspitasari, et al.
Vascular Pharmacology|July 19, 2024
Antithrombotic properties of Tafamidis: An additional protective effect for transthyretin amyloid cardiomyopathy patientsStefano Ministrini, Rebecca Niederberger, Alexander Akhmedov, et al.
European Heart Journal|January 10, 2017
Ticagrelor, but not clopidogrel active metabolite, displays antithrombotic properties in the left atrial endocardiumMartin F Reiner, Alexander Breitenstein, Erik W Holy, et al.
Kidney International|May 9, 2018
The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease riskEva-Maria Pastor-Arroyo, Nicole Gehring, Christiane Krudewig, et al.
International Journal of Cardiology|July 16, 2018
Corrigendum to 'Sirtuin 5 as a novel target to blunt blood-brain barrier damage induced by cerebral ischemia/reperfusion injury' [Int. J. Cardiol. 260 (2018) 148-155]Candela Diaz-Cañestro, Mario Merlini, Nicole R Bonetti, et al.
Thrombosis Research|December 16, 2018
Gut microbiota-dependent trimethylamine-N-oxide (TMAO) shows a U-shaped association with mortality but not with recurrent venous thromboembolismMartin F Reiner, Daniel Müller, Sara Gobbato, et al.
Cardiovascular Research|February 16, 2017
Endothelial LOX-1 activation differentially regulates arterial thrombus formation depending on oxLDL levels: role of the Oct-1/SIRT1 and ERK1/2 pathwaysAlexander Akhmedov, Giovanni G Camici, Martin F Reiner, et al.
European Heart Journal|May 14, 2022
Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts premature death in acute coronary syndromesSimon Kraler, Florian A Wenzl, Georgios Georgiopoulos, et al.
Cardiovascular Research|November 11, 2024
miR-24-3p secreted as extracellular vesicle cargo by cardiomyocytes inhibits fibrosis in human cardiac microtissuesGiorgia Senesi, Alessandra M Lodrini, Shafeeq Mohammed, et al.
Journal of the American Heart Association|June 1, 2023
Omega-3 Fatty Acids and Heart Rhythm, Rate, and Variability in Atrial FibrillationPhilipp Baumgartner, Martin F Reiner, Andrea Wiencierz, et al.
Pageof 18